Imunon, Inc.
IMNN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000749647
In the last 90 days, Imunon, Inc. insiders filed 0 open-market purchases and 5 sales; 23 institutions reported holding it in 13F filings for Q2 2026, worth $506.1K in total; no superinvestor holds it.
13F holders, Q3 2024
Institutional positions in Imunon, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 22
- +5 vs. Q2 2024
- Shares held
- 1.02M
- +701.3K (+222.8%) vs. Q2 2024
- Total value
- $1.08M
- +$702.4K (+187.6%) vs. Q2 2024
- New holders
- 8
- 3 more added
- Sold out
- 3
- 3 more reduced
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IMNN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 23 | $506.1K |
| Q1 2026 | 19 | $1.63M |
| Q4 2025 | 20 | $1.76M |
| Q3 2025 | 17 | $879.0K |
| Q2 2025 | 26 | $1.76M |
| Q1 2025 | 19 | $359.9K |
| Q4 2024 | 22 | $403.5K |
| Q3 2024 | 22 | $1.08M |
| Q2 2024 | 18 | $442.0K |
| Q1 2024 | 18 | $539.4K |
| Q4 2023 | 22 | $285.9K |
| Q3 2023 | 18 | $402.9K |
| Q2 2023 | 17 | $515.1K |
| Q1 2023 | 19 | $513.3K |
| Q4 2022 | 22 | $572.7K |
| Q3 2022 | 22 | $818.1K |
| Q2 2022 | 25 | $1.69M |
| Q1 2022 | 24 | $2.66M |
| Q4 2021 | 42 | $4.14M |
| Q3 2021 | 40 | $8.54M |
| Q2 2021 | 43 | $11.5M |
| Q1 2021 | 47 | $16.4M |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding Imunon, Inc.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royal Bank of Canada | 2 | $0 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 2 | $2 | 0.00% | 00.0% | Unchanged |
| Game Plan Financial Advisors, LLC | 2 | $2 | 0.00% | 00.0% | Unchanged |
| Jones Financial Companies LLLP | 5 | $5 | 0.00% | +5 | New |
| UBS Group AG | 21 | $22 | 0.00% | −12,956−99.8% | Reduced |
| Federation des caisses Desjardins du Quebec | 66 | $70 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 118 | $125 | 0.00% | +41+53.2% | Added |
| Group One Trading, L.P. | 129 | $137 | 0.00% | 00.0% | Unchanged |
| M&R Capital Management Inc | 333 | $353 | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 2,131 | $2.26K | 0.00% | +500+30.7% | Added |
| Tower Research Capital LLC (TRC) | 4,889 | $5.18K | 0.00% | −3,485−41.6% | Reduced |
| Nations Financial Group Inc, | 10,000 | $10.6K | 0.00% | +10,000 | New |
| Two Sigma Securities, LLC | 10,521 | $11.2K | 0.00% | +10,521 | New |
| Jane Street Group, LLC | 12,503 | $13.3K | 0.00% | +12,503 | New |
| Virtu Financial LLC | 15,169 | $16.0K | 0.00% | +15,169 | New |
| State Street Corp | 21,303 | $22.6K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 33,985 | $36.0K | 0.00% | +33,985 | New |
| Vanguard Group Inc | 48,806 | $51.7K | 0.00% | 00.0% | Unchanged |
| BlackRock, Inc. | 58,222 | $61.7K | 0.00% | +58,222 | New |
| Renaissance Technologies LLC | 63,611 | $67.4K | 0.00% | −47,700−42.9% | Reduced |
| Geode Capital Management, LLC | 125,935 | $133.5K | 0.00% | +51,282+68.7% | Added |
| Sabby Management, LLC | 608,203 | $644.7K | 8.93% | +608,203 | New |
| Colony Group, LLC | 0 | $0 | 0.00% | −35,000−100.0% | Sold out |
| Caitlin John, LLC | 0 | $0 | 0.00% | −19−100.0% | Sold out |
| Allworth Financial LP | 0 | $0 | 0.00% | −2−100.0% | Sold out |
| BlackRock Inc. | – | – | – | – | Not filed |